Skip to main content
letter
. 2020 Apr 20;69(8):1543–1544. doi: 10.1136/gutjnl-2020-321388

Figure 1.

Figure 1

Increased FC and serum IL-6 feature acute diarrhoea in COVID-19. (A) FC concentration determined by ELISA. Group A (n=18): COVID-19 patients without diarrhoea. Group B (n=13): COVID-19 patients who reported diarrhoea which ceased 48 hours before stool collection. Group C (n=9): COVID-19 patients with acute diarrhoea (onset <48 hours) (*p<0.001, group B versus group A; **p<0.001, group C versus groups B and A). (B) Correlation of serum IL-6 concentration with FC concentration reported in A. (C) Detection of faecal SARS-CoV-2-RNA by PCR, reported as 1/cycle threshold value. Dashed line indicates threshold of RNA detection. (D) Correlation of faecal SARS-CoV-2-RNA (as in C) with FC. COVID-19, coronavirus disease 2019; FC, faecal calprotectin; IL-6, interleukin-6; SARS-CoV-2, severe acute respiratory syndrome corona virus 2.